Harman Max Bruins
Overview
Explore the profile of Harman Max Bruins including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
1109
Followers
0
Related Specialty
Related Specialty
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Witjes J, Bruins H, Carrion A, Cathomas R, Comperat E, Efstathiou J, et al.
Eur Urol
. 2024 Mar;
85(6):e180.
PMID: 38492977
No abstract available.
2.
Witjes J, Bruins H, Carrion A, Cathomas R, Comperat E, Efstathiou J, et al.
Eur Urol
. 2023 Oct;
85(1):17-31.
PMID: 37858453
Context: We present an overview of the updated 2023 European Association of Urology (EAU) guidelines for muscle-invasive and metastatic bladder cancer (MMIBC). Objective: To provide practical evidence-based recommendations and consensus...
3.
Devlies W, de Jong J, Hofmann F, Bruins H, Zuiverloon T, Smith E, et al.
Eur Urol Focus
. 2023 Aug;
10(1):115-122.
PMID: 37633791
Context: Haematuria can be macroscopic (visible haematuria [VH]) or microscopic (nonvisible haematuria [NVH]), and may be caused by a number of underlying aetiologies. Currently, in case of haematuria, cystoscopy is...
4.
Sylvester R, Rodriguez O, Hernandez V, Turturica D, Bauerova L, Bruins H, et al.
Eur Urol
. 2023 Feb;
83(5):e140-e141.
PMID: 36841687
No abstract available.
5.
van t Hof M, Bruins H, van Roermund J
Curr Opin Urol
. 2021 Jun;
31(6):570-573.
PMID: 34138781
Purpose Of Review: After radical cystectomy (RC) patients are at risk for both benign and malignant problems regarding the upper urinary tract (UUT). This review summarizes the recent literature and...
6.
Sylvester R, Rodriguez O, Hernandez V, Turturica D, Bauerova L, Bruins H, et al.
Eur Urol
. 2021 Jan;
79(4):480-488.
PMID: 33419683
Background: The European Association of Urology (EAU) prognostic factor risk groups for non-muscle-invasive bladder cancer (NMIBC) are used to provide recommendations for patient treatment after transurethral resection of bladder tumor...
7.
Witjes J, Bruins H, Cathomas R, Comperat E, Cowan N, Gakis G, et al.
Eur Urol
. 2020 May;
79(1):82-104.
PMID: 32360052
Context: This overview presents the updated European Association of Urology (EAU) guidelines for muscle-invasive and metastatic bladder cancer (MMIBC). Objective: To provide practical evidence-based recommendations and consensus statements on the...
8.
Peyronnet B, Seisen T, Dominguez-Escrig J, Bruins H, Yuan C, Lam T, et al.
Eur Urol Focus
. 2017 Nov;
5(2):205-223.
PMID: 29154042
Context: Most series have suggested better perioperative outcomes of laparoscopic radical nephroureterectomy (RNU) over open RNU. However, the oncological safety of laparoscopic RNU remains controversial. Objective: To systematically review all...
9.
Boissier R, Hevia V, Bruins H, Budde K, Figueiredo A, Lledo-Garcia E, et al.
Eur Urol
. 2017 Aug;
73(1):94-108.
PMID: 28803033
Context: Renal transplantation is the gold standard renal replacement therapy in end-stage renal disease owing to its superior survival and quality of life compared with dialysis. When the potential recipient...